Literature DB >> 32178356

Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen.

Carole Ayoub Moubareck1, Dalal Hammoudi Halat2.   

Abstract

Being a multidrug-resistant and an invasive pathogen, Acinetobacter baumannii is one of the major causes of nosocomial infections in the current healthcare system. It has been recognized as an agent of pneumonia, septicemia, meningitis, urinary tract and wound infections, and is associated with high mortality. Pathogenesis in A. baumannii infections is an outcome of multiple virulence factors, including porins, capsules, and cell wall lipopolysaccharide, enzymes, biofilm production, motility, and iron-acquisition systems, among others. Such virulence factors help the organism to resist stressful environmental conditions and enable development of severe infections. Parallel to increased prevalence of infections caused by A. baumannii, challenging and diverse resistance mechanisms in this pathogen are well recognized, with major classes of antibiotics becoming minimally effective. Through a wide array of antibiotic-hydrolyzing enzymes, efflux pump changes, impermeability, and antibiotic target mutations, A. baumannii models a unique ability to maintain a multidrug-resistant phenotype, further complicating treatment. Understanding mechanisms behind diseases, virulence, and resistance acquisition are central to infectious disease knowledge about A. baumannii. The aims of this review are to highlight infections and disease-producing factors in A. baumannii and to touch base on mechanisms of resistance to various antibiotic classes.

Entities:  

Keywords:  Acinetobacter baumannii; antibiotics; multidrug resistance; pathogenesis; virulence factors

Year:  2020        PMID: 32178356     DOI: 10.3390/antibiotics9030119

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  48 in total

Review 1.  Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.

Authors:  Ronit Vogt Sionov; Doron Steinberg
Journal:  Microorganisms       Date:  2022-06-16

2.  Light Regulates Acinetobacter baumannii Chromosomal and pAB3 Plasmid Genes at 37°C.

Authors:  Mariah S Squire; Hope A Townsend; Aminul Islam; Luis A Actis
Journal:  J Bacteriol       Date:  2022-05-23       Impact factor: 3.476

3.  Whole-Genome Sequencing of a Colistin-Resistant Acinetobacter baumannii Strain Isolated at a Tertiary Health Facility in Pretoria, South Africa.

Authors:  Noel-David Nogbou; Mbudzeni Ramashia; Granny Marumo Nkawane; Mushal Allam; Chikwelu Lawrence Obi; Andrew Munyalo Musyoki
Journal:  Antibiotics (Basel)       Date:  2022-04-28

4.  Vaccinomics to Design a Multi-Epitopes Vaccine for Acinetobacter baumannii.

Authors:  Miraj Ud-Din; Aqel Albutti; Asad Ullah; Saba Ismail; Sajjad Ahmad; Anam Naz; Muhammad Khurram; Mahboob Ul Haq; Zobia Afsheen; Youness El Bakri; Muhammad Salman; Bilal Shaker; Muhammad Tahir Ul Qamar
Journal:  Int J Environ Res Public Health       Date:  2022-05-04       Impact factor: 4.614

5.  Antimicrobial Photodynamic Therapy Mediated by Fotenticine and Methylene Blue on Planktonic Growth, Biofilms, and Burn Infections of Acinetobacter baumannii.

Authors:  Lívia M A Figueiredo-Godoi; Maíra T Garcia; Juliana G Pinto; Juliana Ferreira-Strixino; Eliseu Gabriel Faustino; Lara Luise Castro Pedroso; Juliana C Junqueira
Journal:  Antibiotics (Basel)       Date:  2022-05-04

Review 6.  Evasion of Antimicrobial Activity in Acinetobacter baumannii by Target Site Modifications: An Effective Resistance Mechanism.

Authors:  Arturo Martínez-Trejo; Juan Manuel Ruiz-Ruiz; Luis Uriel Gonzalez-Avila; Andrés Saldaña-Padilla; Cecilia Hernández-Cortez; Miguel Angel Loyola-Cruz; Juan Manuel Bello-López; Graciela Castro-Escarpulli
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

7.  Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination.

Authors:  Yoshinori Sato; Tsuneyuki Ubagai; Shigeru Tansho-Nagakawa; Yusuke Yoshino; Yasuo Ono
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

8.  C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Acinetobacter baumannii Carbapenemase OXA-23 by Impeding Deacylation.

Authors:  Nichole K Stewart; Marta Toth; Maha A Alqurafi; Weirui Chai; Thu Q Nguyen; Pojun Quan; Mijoon Lee; John D Buynak; Clyde A Smith; Sergei B Vakulenko
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

9.  Pan-Resistome Insights into the Multidrug Resistance of Acinetobacter baumannii.

Authors:  Diego Lucas Neres Rodrigues; Francielly Morais-Rodrigues; Raquel Hurtado; Roselane Gonçalves Dos Santos; Daniela Camargos Costa; Debmalya Barh; Preetam Ghosh; Khalid J Alzahrani; Siomar Castro Soares; Rommel Ramos; Aristóteles Góes-Neto; Vasco Azevedo; Flávia Figueira Aburjaile
Journal:  Antibiotics (Basel)       Date:  2021-05-18

10.  Safety and Therapeutic Efficacy of Thymoquinone-Loaded Liposomes against Drug-Sensitive and Drug-Resistant Acinetobacter baumannii.

Authors:  Khaled S Allemailem; Abdullah M Alnuqaydan; Ahmad Almatroudi; Faris Alrumaihi; Aseel Aljaghwani; Habibullah Khalilullah; Hina Younus; Arif Khan; Masood A Khan
Journal:  Pharmaceutics       Date:  2021-05-08       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.